Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.

Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Ketter TA, Calabrese JR, Thase ME, Bowden CL, Friedman ES, Ostacher MJ, Iosifescu DV, Severe J, Keyes M, Nierenberg AA.

Clin Trials. 2012 Feb;9(1):94-101. doi: 10.1177/1740774511427324. Epub 2011 Nov 10.

2.

Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.

Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Ketter TA, Calabrese JR, Thase ME, Bowden CL, Friedman ES, Ostacher MJ, Novak L, Iosifescu DV; Litmus Study Group.

Clin Trials. 2009 Dec;6(6):637-48. doi: 10.1177/1740774509347399. Epub 2009 Nov 23.

PMID:
19933719
3.

Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials.

Friedman ES, Calabrese JR, Ketter TA, Leon AC, Thase ME, Bowden CL, Sylvia LG, Ostracher MJ, Severe J, Iosifescu DV, Nierenberg AA, Reilly-Harrington NA.

J Affect Disord. 2014 Jan;152-154:97-104. doi: 10.1016/j.jad.2013.05.052. Epub 2013 Jul 8.

PMID:
23845385
4.

Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.

Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Shesler LW, McElroy SL, Friedman ES, Thase ME, Shelton RC, Bowden CL, Tohen M, Singh V, Deckersbach T, Ketter TA, Kocsis JH, McInnis MG, Schoenfeld D, Bobo WV, Calabrese JR; Bipolar CHOICE Study Group.

Clin Trials. 2014 Feb;11(1):114-27. doi: 10.1177/1740774513512184. Epub 2013 Dec 17.

5.

Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.

McElroy SL, Bowden CL, Collins MA, Wozniak PJ, Keck PE Jr, Calabrese JR.

J Affect Disord. 2008 Apr;107(1-3):127-33. Epub 2007 Sep 20.

PMID:
17888516
6.

Medication adherence in a comparative effectiveness trial for bipolar disorder.

Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA.

Acta Psychiatr Scand. 2014 May;129(5):359-65. doi: 10.1111/acps.12202. Epub 2013 Oct 3.

7.

Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.

Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS.

Arch Gen Psychiatry. 2007 Apr;64(4):419-26.

8.

Oxcarbazepine for acute affective episodes in bipolar disorder.

Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004857. doi: 10.1002/14651858.CD004857.pub2. Review.

PMID:
22161387
9.

Use of treatment services in a comparative effectiveness study of bipolar disorder.

Sylvia LG, Iosifescu D, Friedman ES, Bernstein EE, Bowden CL, Ketter TA, Reilly-Harrington NA, Leon AC, Calabrese JR, Ostacher MJ, Rabideau DJ, Thase ME, Nierenberg AA.

Psychiatr Serv. 2013 Nov 1;64(11):1119-26. doi: 10.1176/appi.ps.201200479.

PMID:
23945956
10.

Olanzapine in long-term treatment for bipolar disorder.

Cipriani A, Rendell JM, Geddes J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004367. doi: 10.1002/14651858.CD004367.pub2. Review.

PMID:
19160237
11.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM.

Cochrane Database Syst Rev. 2001;(3):CD003196. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD003196.

PMID:
11687047
12.

Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.

Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):94-9. doi: 10.1016/j.pnpbp.2008.10.012. Epub 2008 Oct 31.

PMID:
19007842
13.

The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.

Sylvia LG, Rabideau DJ, Nierenberg AA, Bowden CL, Friedman ES, Iosifescu DV, Thase ME, Ketter T, Greiter EA, Calabrese JR, Leon AC, Ostacher MJ, Reilly-Harrington N.

J Affect Disord. 2014 Dec;169:144-8. doi: 10.1016/j.jad.2014.08.019. Epub 2014 Aug 20.

14.

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.

Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.

Curr Med Res Opin. 2010 Jun;26(6):1485-96. doi: 10.1185/03007991003779380.

PMID:
20429835
15.

Re-evaluation of randomized controlled trials of lithium monotherapy.

Severus WE, Kleindienst N, Greil W.

Bipolar Disord. 2006 Oct;8(5 Pt 1):519-20; author reply 521. No abstract available.

PMID:
17042892
16.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
17.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

18.

Lithium for maintenance treatment of mood disorders.

Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G.

Cochrane Database Syst Rev. 2001;(3):CD003013. Review.

PMID:
11687035
19.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

20.

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

Smith LA, Cornelius V, Warnock A, Bell A, Young AH.

Bipolar Disord. 2007 Jun;9(4):394-412. Review.

PMID:
17547586
Items per page

Supplemental Content

Write to the Help Desk